VELBAN
VINBLASTINE SULFATE
Approval overview VELBAN is listed in Drugs@FDA under application 012665 (NDA).
Marketing status: Discontinued Active ingredient VINBLASTINE SULFATE Form and strength INJECTABLE;INJECTION - 10MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor LILLY Submission history Latest submission status date: 2007-12-07 00:00:00.
Structured Monograph
Clinical summary
Approval overview VELBAN is listed in Drugs@FDA under application 012665 (NDA). Marketing status: Discontinued Active ingredient VINBLASTINE SULFATE Form and strength INJECTABLE;INJECTION - 10MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor LILLY Submission history Latest submission status date: 2007-12-07 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.